An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex

The MBD2-NuRD (Nucleosome Remodeling and Deacetylase) complex is an epigenetic reader of DNA methylation that regulates genes involved in normal development and neoplastic diseases. To delineate the architecture and functional interactions of the MBD2-NuRD complex, we previously solved the structures of MBD2 bound to methylated DNA and a coiled-coil interaction between MBD2 and p66α that recruits the CHD4 nucleosome remodeling protein to the complex. The work presented here identifies novel structural and functional features of a previously uncharacterized domain of MBD2 (MBD2IDR). Biophysical analyses show that the MBD2IDR is an intrinsically disordered region (IDR). However, despite this inherent disorder, MBD2IDR increases the overall binding affinity of MBD2 for methylated DNA. MBD2IDR also recruits the histone deacetylase core components (RbAp48, HDAC2 and MTA2) of NuRD through a critical contact region requiring two contiguous amino acid residues, Arg286 and Leu287. Mutating these residues abrogates interaction of MBD2 with the histone deacetylase core and impairs the ability of MBD2 to repress the methylated tumor suppressor gene PRSS8 in MDA-MB-435 breast cancer cells. These findings expand our knowledge of the multi-dimensional interactions of the MBD2-NuRD complex that govern its function.

[1]  G. Hong,et al.  Nucleic Acids Research , 2015, Nucleic Acids Research.

[2]  M. Vermeulen,et al.  Towards elucidating the stability, dynamics and architecture of the nucleosome remodeling and deacetylase complex by using quantitative interaction proteomics , 2015, The FEBS journal.

[3]  Ninad M Walavalkar,et al.  Solution structure and intramolecular exchange of methyl-cytosine binding domain protein 4 (MBD4) on DNA suggests a mechanism to scan for mCpG/TpG mismatches , 2014, Nucleic acids research.

[4]  Jignesh R. Parikh,et al.  Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. , 2014, Cell stem cell.

[5]  A. H. Smits,et al.  Insight into the Architecture of the NuRD Complex , 2014, The Journal of Biological Chemistry.

[6]  Daniel H. Miller,et al.  Targeting the disordered C-terminus of PTP1B with an allosteric inhibitor , 2014, Nature chemical biology.

[7]  Daiwen Yang,et al.  Transcriptional Repressor Domain of MBD1 is Intrinsically Disordered and Interacts with its Binding Partners in a Selective Manner , 2014, Scientific Reports.

[8]  Alexander K. Buell,et al.  Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease , 2014, PloS one.

[9]  David C Williams,et al.  Probing the Dynamic Distribution of Bound States for Methylcytosine-binding Domains on DNA* , 2013, The Journal of Biological Chemistry.

[10]  Bishnu Bhattacharyya,et al.  Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2. , 2013, Carcinogenesis.

[11]  Vladimir N. Uversky,et al.  The roles of intrinsic disorder in protein interaction networks , 2013 .

[12]  C. Robinson,et al.  Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates , 2013, Molecular cell.

[13]  R. Andersen,et al.  An androgen receptor N-terminal domain antagonist for treating prostate cancer. , 2013, The Journal of clinical investigation.

[14]  N. Gordon,et al.  Unique Features of the Anti-parallel, Heterodimeric Coiled-coil Interaction between Methyl-cytosine Binding Domain 2 (MBD2) Homologues and GATA Zinc Finger Domain Containing 2A (GATAD2A/p66α)* , 2012, The Journal of Biological Chemistry.

[15]  P. Tompa.  Intrinsically disordered proteins: a 10-year recap. , 2012, Trends in biochemical sciences.

[16]  Anthony A. Hyman,et al.  Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics , 2012, Nucleic acids research.

[17]  Xiaodong Cheng,et al.  Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation , 2012, Nucleic acids research.

[18]  Vladimir N Uversky,et al.  Intrinsically disordered proteins from A to Z. , 2011, The international journal of biochemistry & cell biology.

[19]  H. Bear,et al.  Methyl-Binding Domain Protein 2–Dependent Proliferation and Survival of Breast Cancer Cells , 2011, Molecular Cancer Research.

[20]  F. Poulsen,et al.  Sequence correction of random coil chemical shifts: correlation between neighbor correction factors and changes in the Ramachandran distribution , 2011, Journal of biomolecular NMR.

[21]  David C. Williams,et al.  Solution structure and dynamic analysis of chicken MBD2 methyl binding domain bound to a target-methylated DNA sequence , 2011, Nucleic acids research.

[22]  Ninad M Walavalkar,et al.  p66α–MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2–NuRD complex , 2011, Proceedings of the National Academy of Sciences.

[23]  Stefanos Labropoulos,et al.  MBD2 contributes to developmental silencing of the human ε-globin gene. , 2011, Blood cells, molecules & diseases.

[24]  L. Gierasch,et al.  Unique physical properties and interactions of the domains of methylated DNA binding protein 2. , 2010, Biochemistry.

[25]  B. Foster,et al.  Nrf2 Expression Is Regulated by Epigenetic Mechanisms in Prostate Cancer of TRAMP Mice , 2010, PloS one.

[26]  Robert S Illingworth,et al.  CpG islands – ‘A rough guide’ , 2009, FEBS letters.

[27]  Ariele Viacava Follis,et al.  Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc. , 2009, Journal of the American Chemical Society.

[28]  Israel Steinfeld,et al.  Developmental programming of CpG island methylation profiles in the human genome , 2009, Nature Structural &Molecular Biology.

[29]  S. Pradhan,et al.  Epigenetic mechanisms in mammals , 2008, Cellular and Molecular Life Sciences.

[30]  M. Fraga,et al.  Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins , 2008, Oncogene.

[31]  A. Fersht,et al.  Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain , 2008, Proceedings of the National Academy of Sciences.

[32]  M. Esteller.  Epigenetics in cancer. , 2008, The New England journal of medicine.

[33]  Valerie H Adams,et al.  Intrinsic Disorder and Autonomous Domain Function in the Multifunctional Nuclear Protein, MeCP2* , 2007, Journal of Biological Chemistry.

[34]  A Keith Dunker,et al.  Characterization of molecular recognition features, MoRFs, and their binding partners. , 2007, Journal of proteome research.

[35]  A. Bird,et al.  MBD2 Is Required for Correct Spatial Gene Expression in the Gut , 2007, Molecular and Cellular Biology.

[36]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[37]  E. Kransdorf,et al.  MBD2 is a critical component of a methyl cytosine-binding protein complex isolated from primary erythroid cells. , 2006, Blood.

[38]  Marc S. Cortese,et al.  Analysis of molecular recognition features (MoRFs). , 2006, Journal of molecular biology.

[39]  Lilia M. Iakoucheva,et al.  Intrinsic Disorder Is a Common Feature of Hub Proteins from Four Eukaryotic Interactomes , 2006, PLoS Comput. Biol..

[40]  K. Gaensler,et al.  Methyl binding domain protein 2 mediates γ-globin gene silencing in adult human βYAC transgenic mice , 2006 .

[41]  Haruki Nakamura,et al.  Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks , 2006, FEBS letters.

[42]  J. Leers,et al.  p66α and p66β of the Mi-2/NuRD complex mediate MBD2 and histone interaction , 2006, Nucleic acids research.

[43]  Marc S. Cortese,et al.  Flexible nets , 2005, The FEBS journal.

[44]  Wayne Boucher,et al.  The CCPN data model for NMR spectroscopy: Development of a software pipeline , 2005, Proteins.

[45]  T. Rauch,et al.  MBD3L2 Interacts with MBD3 and Components of the NuRD Complex and Can Oppose MBD2-MeCP1-mediated Methylation Silencing* , 2005, Journal of Biological Chemistry.

[46]  G. Pfeifer,et al.  MBD3L1 Is a Transcriptional Repressor That Interacts with Methyl-CpG-binding Protein 2 (MBD2) and Components of the NuRD Complex* , 2004, Journal of Biological Chemistry.

[47]  Johannes Buchner,et al.  The N-terminal domain of p53 is natively unfolded. , 2003, Journal of molecular biology.

[48]  G. Clore,et al.  Solution Structure of the Phosphoryl Transfer Complex between the Signal-transducing Protein IIAGlucose and the Cytoplasmic Domain of the Glucose Transporter IICBGlucose of the Escherichia coli Glucose Phosphotransferase System* , 2003, Journal of Biological Chemistry.

[49]  A. Bird,et al.  Deficiency of Mbd2 suppresses intestinal tumorigenesis , 2003, Nature Genetics.

[50]  R. Kingston,et al.  Calcium Phosphate Transfection , 2003, Current protocols in cell biology.

[51]  Esteban Ballestar,et al.  The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. , 2003, Nucleic acids research.

[52]  A. Cooney,et al.  MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor. , 2002, Genomics.

[53]  F. Ishikawa,et al.  The mCpG-binding Domain of Human MBD3 Does Not Bind to mCpG but Interacts with NuRD/Mi2 Components HDAC1 and MTA2* , 2002, The Journal of Biological Chemistry.

[54]  Marc S. Lewis,et al.  Modern analytical ultracentrifugation in protein science: A tutorial review , 2002, Protein science : a publication of the Protein Society.

[55]  D. Boger,et al.  Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[56]  K. Chai,et al.  Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation , 2002, International journal of cancer.

[57]  R. Singal,et al.  Methylation of Promoter Proximal-transcribed Sequences of an Embryonic Globin Gene Inhibits Transcription in Primary Erythroid Cells and Promotes Formation of a Cell Type-specific Methyl Cytosine Binding Complex* , 2002, The Journal of Biological Chemistry.

[58]  N. Greenberg,et al.  Down‐regulation of prostasin serine protease: A potential invasion suppressor in prostate cancer , 2001, The Prostate.

[59]  A. Wolffe,et al.  Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  V. Uversky,et al.  Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.

[61]  G. Seydoux,et al.  PIE-1 is a bifunctional protein that regulates maternal and zygotic gene expression in the embryonic germ line of Caenorhabditis elegans. , 2001, Genes & development.

[62]  O. Smart,et al.  Photo-control of helix content in a short peptide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Schuck,et al.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. , 2000, Biophysical journal.

[64]  A. Bird,et al.  Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins , 1998, Molecular and Cellular Biology.

[65]  P E Wright,et al.  Recommendations for the presentation of NMR structures of proteins and nucleic acids. , 1998, Journal of molecular biology.

[66]  K. Wüthrich,et al.  Recommendations for the presentation of NMR structures of proteins and nucleic acids – IUPAC-IUBMB-IUPAB Inter-Union Task Group on the Standardization of Data Bases of Protein and Nucleic Acid Structures Determined by NMR Spectroscopy , 1998, European journal of biochemistry.

[67]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[68]  B. Pontius.  Close encounters: why unstructured, polymeric domains can increase rates of specific macromolecular association. , 1993, Trends in biochemical sciences.

[69]  A. Bird,et al.  Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs , 1989, Cell.

[70]  Monika Fuxreiter,et al.  Fuzzy complexes: a more stochastic view of protein function. , 2012, Advances in experimental medicine and biology.

[71]  Monika Fuxreiter,et al.  Fuzziness: linking regulation to protein dynamics. , 2012, Molecular bioSystems.

[72]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[73]  M. Kimmel,et al.  Conflict of interest statement. None declared. , 2010 .

[74]  G. D. Ginder,et al.  Methyl binding domain protein 2 mediates gamma-globin gene silencing in adult human betaYAC transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[75]  Q. Feng,et al.  The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. , 2001, Genes & development.

[76]  Obradovic,et al.  Predicting Protein Disorder for N-, C-, and Internal Regions. , 1999, Genome informatics. Workshop on Genome Informatics.

[77]  Romero,et al.  Sequence Data Analysis for Long Disordered Regions Prediction in the Calcineurin Family. , 1997, Genome informatics. Workshop on Genome Informatics.

[78]  D. Hochstrasser,et al.  The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences , 1993, Electrophoresis.